Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotype

Cancer Gene Therapy

Volumn 8, Issue 7, 2001, Pages 522-528

  Krueger, Sabine ^a   Kellner, Udo ^a   Buehling, Frank ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Antisense; Cathepsin L; Oligonucleotides

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CATHEPSIN L; COLLAGEN TYPE 1; MATRIGEL; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASEMENT MEMBRANE; BLOTTING, NORTHERN; CATHEPSIN B; CATHEPSINS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; COLLAGEN; CYSTEINE ENDOPEPTIDASES; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LAMININ; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; OSTEOSARCOMA; PHENOTYPE; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034903658     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700341     Document Type: Article

References (32)

1. Biology and biochemistry of proteinases in tumor invasion
2. The malignant phenotype and cysteine proteinases
3. Cysteinprotease and tumor progression
4. Cysteine proteinases in cancer progression and their clinical relevance for prognosis
5. Unraveling the role of proteases in cancer
6. Cathepsin B, Cathepsin H, Cathepsin L
7. Expression of cathepsin L in human tumors
8. Cathepsin b, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients
9. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer
10. Prognostic significance of cathepsin B and L in primary human breast cancer
11. Cathepsin B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue
12. Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L
13. Hybridoma cells producing antibodies to cathepin L have greatly reduced potential for tumour growth
14. Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64
15. Inhibition of motility and invasion of B16 melanoma by the overexpression of cystatin C
16. Inhibition of tumour cell invasion by protease inhibitors: Correlation with protease profile
17. Specific regulation of gene expression by antisense, sense and antigen nucleic acids
18. Concentration of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney
19. Cathepsin D, B, and L in malignant human lung tissue
20. Cathepsin D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC)
21. Immunohistochemical analysis of cathepsin D, B, and L in human breast cancer
22. Cysteine and serine proteases in gastric cancer
23. Expression of cysteine protease inhibitors in human gliomas and meningiomas
24. Enhanced expression of cathepsin L in metastatic bone tumors
25. Antisense strategies in cell and developmental biology
26. Gene inhibition using antisense oligodeoxynucleotides
27. Inhibition of translation initiation by antisense oligonucleotides via an Rnase H independent mechanism
28. Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides
29. Kinetic characteristics of Escherichia coli RNase H1: Cleavage of various antisense oligonucleotide - RNA duplexes
30. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells
31. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line
32. Antisense inhibition of urokinase: Effect on malignancy in a human osteosarcoma cell line